Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three ...

The FDA's controversial rejection of a skin cancer therapy from Replimune Group has prompted Krystal Biotech to shut down of ...

Correa and Bergman are co-chairs of the congressional Psychedelics Advancing Therapies (PATH) Caucus. Mercer is a Marine ...

Neuroscientists have long held that the brain reorganizes itself when a body part is amputated. A new study says that’s not ...

Good morning. We've got a meaty issue for you today. In particular, I urge you to spend some time with Jason Mast's story. It's another heartbreaking ...

A new heart risk model had raised questions about who should take statins. A new study to "right-size" yields a similar ...

Soleno Therapeutics CEO responds to a 415-page short-seller report alleging safety issues tied to the company's newly approved therapy.

Provide your payment details. The free trial associated with this subscription will be appended to the standard duration of ...

New additions introduced by Faulkner and others include an AI scribe powered by Microsoft to rival products from health tech ...

Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

After deaths and FDA setbacks, Sarepta abandoned LGMD gene therapy, leaving families desperate and patients without long-promised treatments.